483 GlaxoSmithKline Biologicals SA Sep 2007

483 GlaxoSmithKline Biologicals SA Sep 2007

Rebecca Olin FDA, Gang Wang FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observations (via FDA 483) on 21 Sep 2007.

Product details

  • Category: Biologics
  • Inspection end: 21 Sep 2007
  • Location: Rixensart, Belgium
  • FEI: 3002875226
Add To Cart